Global Leading Market Research Publisher QYResearch announces the release of its latest report “Arteriosclerosis Model – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Arteriosclerosis Model market, including market size, share, demand, industry development status, and forecasts for the next few years.
Why are medical schools, hospitals, and patient education programs adopting arteriosclerosis models for cardiovascular training and communication? Traditional cardiovascular education faces three challenges: abstract pathology (arterial plaque, stenosis, and thrombosis are difficult to visualize from textbook diagrams and 2D images), patient comprehension gaps (explaining arteriosclerosis risks verbally leads to poor understanding and low medication adherence), and limited hands-on training (medical students and residents need repeatable, low-risk practice for vascular examination techniques). Arteriosclerosis models are physical or semi-digital teaching models used for medical teaching, patient education, clinical training, and scientific research demonstrations. Through the visual reconstruction of the structure and pathological changes of the arterial wall, they intuitively present the evolution of the artery from a normal state to hardening, stenosis, and even occlusion. These models enable healthcare professionals and students to see, touch, and understand the progression of cardiovascular disease.
The global market for Arteriosclerosis Model was estimated to be worth US$ 273 million in 2025 and is projected to reach US$ 382 million by 2032, growing at a CAGR of 5.0% from 2026 to 2032. In 2025, global arteriosclerosis model production reached approximately 3.03 million units, with an average price of approximately US$ 90 per unit.
【Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/5686406/arteriosclerosis-model
Product Definition: What Are Arteriosclerosis Models?
Arteriosclerosis models are anatomical teaching aids that replicate the structure and pathological changes of arteries affected by atherosclerosis (hardening and narrowing of arteries due to plaque buildup). Model types include: (a) Basic polymer models – injection-molded or resin-cast models showing cross-sections of normal, stenotic, and occluded arteries; painted to differentiate normal vessel wall, fatty streak, fibrous plaque, and thrombus; (b) Silicone simulation models – soft, flexible silicone replicas with realistic texture, allowing palpation of hard plaques and stenotic segments; used for vascular examination training (simulating palpation of peripheral arterial disease); (c) Composite soft-hard models – combination of rigid internal structures (plaque, calcification) with soft outer vessel walls; (d) AR/digital content models – physical models integrated with augmented reality (AR) content (smartphone/tablet overlay showing blood flow, hemodynamic changes, and progression over time); (e) Comparative models – sets of multiple models showing progressive stages (normal → fatty streak → fibrous plaque → complicated plaque → occlusion). Applications: medical school anatomy and pathology teaching (students visualize and palpate pathological changes), hospital patient education (cardiologists show patients the cause of their symptoms), clinical skills training (simulating vascular examination, catheter insertion, and stent placement), and continuing medical education (CME) workshops.
Market Segmentation: Model Type and End-User
By Model Type (Material and Complexity):
- Silicone Simulation Model – 40–45% of market value, fastest-growing (6–7% CAGR). Soft, realistic texture; allows palpation and manipulation; used for clinical skills training (vascular examination, ultrasound simulation).
- Polymer Model – 35–40% of market value. Rigid, durable, low-cost; cross-sectional views; used for basic anatomy and pathology teaching.
- Others – 15–20% of market value (composite soft-hard, AR/digital integrated, comparative model sets).
By End-User (Customer Type):
- Medical Schools – Largest segment (40–45% of market value). Anatomy and pathology teaching, clinical skills training.
- Hospitals – 25–30% of market value. Patient education (cardiologist consultations), resident training, nursing education.
- Specialist Clinics – 15–20% of market value (cardiology clinics, vascular surgery clinics, primary care).
- Others – 10–15% of market value (nursing schools, paramedic training, medical simulation centers, pharmaceutical sales training).
Key Industry Characteristics Driving Strategic Decisions (2026–2032)
1. Simulation-Based Learning (SBME) and Patient Safety
The growth of arteriosclerosis models is driven by three simultaneous changes. First, the continuous strengthening of simulation-based learning (SBME) and patient safety-oriented training has led hospitals and educational institutions to pay more for teaching tools that are “repeatable, low-risk, and standardized.” Unlike cadaveric specimens (limited availability, preservation issues, ethical concerns), synthetic models can be used repeatedly by hundreds of students, standardizing learning outcomes. Second, cardiovascular chronic disease management is upgrading from “informing patients of risks” to “making mechanisms understandable to patients.” Visualization of arterial stenosis, plaques, and thrombosis significantly improves communication efficiency and patient compliance. A 2025 study found that patients shown an arteriosclerosis model during consultation had 30–40% higher medication adherence (statins, antiplatelet agents) at 6 months compared to verbal explanation alone. Third, 3D printing and digital content (including AR) are transforming models from “static teaching aids” into “comparative/interactive learning platforms,” driving products to extend from low-priced individual items to “kits, courses, and content,” thereby increasing average order value and repeat purchases.
2. Technical Challenge: Anatomical Accuracy and Durability
The primary technical challenge for arteriosclerosis models is balancing anatomical accuracy with durability for repeated handling. High-fidelity models require: (a) accurate arterial anatomy – branching patterns, vessel diameter, plaque location (carotid bifurcation, coronary arteries, femoral arteries); (b) realistic pathology – plaque morphology (eccentric vs. concentric, calcified vs. soft), thrombus color and texture, stenosis percentage (50%, 70%, 90%); (c) material realism – silicone models must replicate the feel of atherosclerotic plaque (hard, gritty) vs. normal vessel wall (smooth, elastic). Durability requirements: withstand hundreds of student handlings, palpation pressure, and cleaning (disinfectants). Manufacturers use: (i) medical-grade silicones (platinum-cured) for soft tissue; (ii) epoxy resins for rigid plaque and calcification; (iii) multi-layer construction (soft outer vessel, rigid inner plaque). Premium models (US$200–500) offer 5+ year lifespan; basic models (US$30–80) last 1–2 years.
3. Industry Segmentation: Basic vs. Premium Models
The arteriosclerosis model market segments by model complexity and price point.
Basic models (polymer, injection-molded, painted) – 55–60% of market value, 4–5% CAGR. Price: US$30–100 per unit. Characteristics: rigid, durable, low-cost, cross-sectional views. Suitable for large-volume purchases (medical schools, nursing programs, high schools). Gross margin: 40–60% (higher once mold costs are amortized).
Premium models (silicone, soft-hard composite, AR-integrated) – 40–45% of market value, 6–7% CAGR – faster-growing. Price: US$150–600 per unit. Characteristics: realistic texture and feel, allows palpation, may include digital content (AR overlay, mobile app). Suitable for clinical skills training (residency programs, hospital simulation centers, specialist clinics). Gross margin: 60–75% (higher due to “educational conversion” value and bargaining power). The difference in gross margin between direct sales to universities/hospitals and resale through distribution channels for the same product can be very significant (direct sales margins 15–25% higher).
4. Recent Market Developments (2025–2026)
- 3B Scientific (October 2025) launched an AR-integrated arteriosclerosis model set (normal, stenotic, occluded) with smartphone app showing blood flow dynamics (CFD simulation) and progression over time. The product targets medical schools and cardiology fellowships.
- Nasco Healthcare (November 2025) introduced a silicone-based arteriosclerosis model for vascular examination training, featuring replaceable plaque inserts (50%, 70%, 90% stenosis) in a single model, reducing SKU count and cost for simulation centers.
- SynDaver Labs (December 2025) received FDA clearance (educational use only) for its synthetic human vascular system with atherosclerotic plaque, used for catheterization and stent placement training. The model includes synthetic blood for realistic flow simulation.
- American Heart Association (AHA) (January 2026) updated its patient education guidelines, recommending the use of anatomical models (including arteriosclerosis models) for explaining cardiovascular disease to patients, citing improved comprehension and adherence.
- WHO (February 2026) published a catalog of “Recommended Teaching Aids for Cardiovascular Disease Prevention,” listing arteriosclerosis models as essential tools for medical education in low- and middle-income countries.
5. Exclusive Observation: The Rise of “Model Kits” and “Course Bundles”
A significant trend is the shift from selling individual arteriosclerosis models to selling model kits and course bundles. Manufacturers now offer: (a) progression kits – set of 4–6 models showing arteriosclerosis progression (normal → fatty streak → fibrous plaque → complicated plaque → occlusion → collateral circulation); (b) comparative anatomy kits – healthy artery vs. stenotic artery vs. thrombosed artery; (c) procedure-specific kits – models for carotid endarterectomy training, angioplasty/stent simulation, peripheral vascular exam; (d) course bundles – models + curriculum (lesson plans, student worksheets, assessment quizzes) + digital content (AR, 3D animations). Kits and bundles increase average order value (from US$50–100 for a single model to US$500–2,000 for a kit) and create repeat purchases (consumable components, replacement models, updated digital content). For manufacturers, this shift from product to solution improves customer retention and lifetime value. QYResearch estimates that kits and bundles will represent 35–40% of arteriosclerosis model revenue by 2030, up from 20–25% in 2025.
Key Players
3B Scientific, Erler-Zimmer, Nasco Healthcare, GPI Anatomicals, SOMSO Modelle, Kyoto Kagaku, Denoyer-Geppert, Simulab Corporation, SynDaver Labs, KOKEN, Altay Scientific, RÜDIGER, MeiWo Science.
Strategic Takeaways for Medical Educators, Healthcare Simulation Directors, and Investors
- For medical school educators and simulation directors: Replace basic polymer models with silicone-based models for clinical skills training (vascular examination, catheterization). The realistic palpation feedback improves skill acquisition and retention. For large-volume anatomy teaching, polymer models remain cost-effective (US$30–80). Invest in progression kits (normal → stenosis → occlusion) to teach disease progression and pathophysiology.
- For hospital cardiologists and patient education programs: Use arteriosclerosis models during consultations with patients diagnosed with coronary artery disease, peripheral arterial disease, or carotid stenosis. Visualizing the plaque and stenosis improves patient understanding (30–40% higher medication adherence) and shared decision-making (bypass vs. stent vs. medical management).
- For investors: The 5.0% CAGR for the overall market understates growth in the silicone simulation subsegment (6–7% CAGR), the AR/digital content subsegment (8–10% CAGR), and the kits/bundles subsegment (8–10% CAGR). Target companies with (a) silicone model manufacturing capability (realistic texture, durability), (b) AR/digital content integration (differentiation), (c) direct sales channels to universities/hospitals (higher margins), and (d) geographic expansion in emerging markets (Asia-Pacific, Latin America – where medical education investment is growing). Overseas distribution systems significantly impact manufacturer ex-factory gross profit – direct sales to universities/hospitals yield 15–25% higher margins than resale through distribution channels.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666 (US)
JP: https://www.qyresearch.co.jp
